netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
  • CONTACT US
No announcement available or all announcement expired.
netscientific
netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
  • CONTACT US

Wanda launches new digital health app Wanda CareLink™ with enhanced real-time capabilities on iOS and Android devices

Aug 15, 2018
-
News, RNS Announcements

London, UK – August 15, 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that portfolio company Wanda, which uses machine learning to help healthcare providers to better manage the risk and care of patients, has launched its new digital health application Wanda CareLink™. This application allows the Wanda Patient Management solution to be used on a wide variety of internet-enabled devices including iOS and Android devices. This enhances the ability for patients and doctors alike to improve clinical and financial outcomes.

 

The application is available on the Apple Store and is to become available on Google Play shortly.

 

Commenting on the news, Francois R. Martelet, NetScientific’s Chief Executive Officer and Chairman of Wanda, said: “Wanda continues to improve its capabilities to match the needs of the market and its clients, and we believe that it will result in increased traction as healthcare providers realise the value of remote patient monitoring from both a financial and clinical standpoint. We are pleased to see Wanda’s progress in strengthening its core offering and look forward to further progress.”

 

NetScientific holds a 62% stake on a fully diluted basis in Wanda. The full announcement is included below.

 

For more information, please contact:

 

  NetScientific

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

Tel: +44 (0)20 3514 1800
  Wanda, Inc.

Bill Basset, CCO

 

Tel: +1 (0)206 910 0428

  Consilium Strategic Communications

Mary-Jane Elliott / Chris Welsh / Laura Thornton

 

 

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

WHIreland (NOMAD and Broker)

Chris Fielding / Jessica Cave / Chris Viggor

Tel: +44 (0)20 7220 1666

 

 

About NetScientific

 

NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net

 

 

Predictive Patient Management Platform Expands Real-Time Mobile Capabilities

August 15, 2018 (San Francisco, CA) — Wanda is pleased to announce the release of its new digital health application Wanda CareLink™. The multi-platform application greatly expands the mobility of the Wanda Patient Management solution to be used on virtually any internet-enabled device including iOS and Android smartphones and tablets. The “bring-your-own-device” approach expands the ability for patients, doctors, and clinicians to improve care plan adherence producing better clinical and financial outcomes.

The Wanda platform empowers doctors and clinicians with the ability to know when patients will have adverse events before they happen, predicting 90% of rehospitalizations and emergency department visits seven days before they occur. The embedded predictive algorithms identify high-risk patients, alerting doctors and clinicians to the root-causes triggering the adverse events. These insights help clinical teams to assess care plans and proactively manage virtual interventions, which improve patient care plan adherence and resolve the adverse event before it happens.

“Wanda is proving to be a great solution for supporting preventative patient engagement with 74% of patients staying adherent to their care plan,” stated William Bassett, Chief Commercial Officer at Wanda. “As high-risk patients are identified, Wanda facilitates better decision making, empowering doctors and clinicians with the real-time insight that will keep patients from preventable emergent situations.”

The Wanda application was created from twelve years of research at UCLA, in a collaborative research project including the Medical, Nursing and Engineering Schools. After eight clinical trials yielding nine patents, the machine learning clinical algorithms have shown to predict 90% of adverse events, rehospitalizations and ED visits, seven days before the event will occur. Wanda warns of the pending adverse event detailing the risk triggers for each patient prompting the need for intervention and then facilitates clinical case management.

“Providers and payers can more easily identify and eliminate issues that have made population health and risk-based contracting a challenge,” said Ahsan Samiee, Chief Technology Officer at Wanda. “The embedded data science in Wanda can now be used across a range of mobile tools to expand the efficiency of real-time patient care.”

 

About Wanda, Inc.

Wanda is dedicated to advancing the effectiveness and efficiency of medicine by using machine learning and modern software applications that empower payers and providers to better manage the risk and care of patients dramatically lowering the cost of care and improving outcomes. More information about Wanda can be found at http://www.yourwanda.com

 

Share on FacebookShare on TwitterShare on Linkedin
← PREVIOUS POST
ProAxsis Immunoassays Selected for Large-Scale ERS-Funded BRIDGE Respiratory Trial
NEXT POST →
ProAxsis strengthens respiratory diagnostic portfolio by receiving CE Mark for third respiratory immunoassay

 

NetScientific plc

Level 39,
One Canada Square,
London, E14 5AB

Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net

  • RNS & RNS Reach
  • Financial Results
  • Financial Calendar
  • Corporate Governance
  • News
  • Historic Material
copyright
Terms of Use
Wanda launches new digital health app Wanda CareLink™ with enhanced real-time capabilities on iOS and Android devices - NetScientific
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.